Diagnoss is a health care startup founded in 2018 and based in the United States. The company's slogan, "Diagnoss is an AI company enhancing EHR productivity for clinical teams," succinctly encapsulates its mission. Diagnoss leverages AI to enhance electronic health record (EHR) productivity for clinical teams by helping medical providers select better medical codes. Their goal is to eliminate the administrative burden associated with medical coding, allowing providers to spend more time with their patients, assisting coders in handling more charts, and providing administrators with peace of mind. The team at Diagnoss comprises world-class data scientists, engineers, clinicians, and serial entrepreneurs with deep experience in healthcare analytics and operations, underlining their commitment to expertise and innovation in the health tech space. Notably, the startup has received backing from The House Fund, contributing to their credibility and financial stability. Diagnoss's vision to streamline medical coding processes and improve overall operational efficiency in healthcare aligns with the growing demand for advanced technological solutions in the industry. With its innovative approach and experienced team, Diagnoss presents a compelling investment opportunity for venture capitalists seeking to support impactful advancements in healthcare technology.
There is no investment information
No recent news or press coverage available for Diagnoss.